US2008032339A1PendingUtilityA1
Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
Est. expiryJul 2, 2017(expired)· nominal 20-yr term from priority
C07K 14/3156C07H 21/02A61K 31/7052A61K 39/092C07K 14/315C07H 21/04A61P 31/04A61K 2039/53A61K 39/00
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
Claims
exact text as granted — not AI-modified1 . A method of making a S. pneumoniae polypeptide, comprising the step of culturing a host cell that includes a recombinant expression vector, wherein the recombinant expression vector includes a nucleic acid sequence encoding a polypeptide having an amino acid sequence as set forth in SEQ ID NO: 5225.
2 . The method of claim 1 , further including the step of isolating the polypeptide from the host cell.
3 . The method of claim 1 , wherein the host cell is a prokaryotic host cell.
4 . The method of claim 3 , wherein the prokaryotic host cell is selected from the group consisting of E. coli, B. subtilis and S. aureus.
5 . The method of claim 4 , wherein the prokaryotic host cell is E. coli.
6 . The method of claim 1 , wherein the host cell is a eukaryotic host cell.
7 . The method of claim 6 , wherein the eukaryotic host cell is selected from the group consisting of an insect cell, a yeast cell and a mammalian cell.
8 . The method of claim 7 , wherein the insect cell is a baculovirus insect cell.
9 . The method of claim 7 , wherein the mammalian cell is a Chinese hamster ovary cell.
10 . The method of claim 1 , wherein the polypeptide elicits an immune response.
11 . The method of claim 1 , wherein the polypeptide provides protective immunity against an infection by S. pneumoniae.
12 . A method of making a S. pneumoniae polypeptide, comprising the step of culturing a host cell that includes a recombinant expression vector, wherein the recombinant expression vector includes a nucleic acid sequence encoding a polypeptide having at least 95% identity to an amino acid sequence as set forth in SEQ ID NO: 5225.
13 . The method of claim 12 , further including the step of isolating the polypeptide from the host cell.Join the waitlist — get patent alerts
Track US2008032339A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.